Breast Cancer Treatment
Herceptin study: 'Shorter therapy just as good'
8 Dec 2017
A new study has revealed that women taking the expensive anti cancer drug, Herceptin, have similar survival rates regardless of whether they take it for nine weeks or a year. In 2007 Pharmac was… Audio